
An earlier diagnosis can mean a different life. That idea ran through every talk at MassBio’s 13th annual Patient Advocacy Summit, held November 12 at the MassBioHub in Cambridge.
This year’s program followed the patient journey from the first sign that something is wrong through diagnosis, treatment, transplant and the life that comes after. MassBio Head of Government Affairs Ed Coppinger shared his 25 years as a kidney patient. Keynote speaker Michelle Werner, executive vice president and president of North America at Ipsen, spoke as both an industry leader and the mother of a son with Duchenne…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks

